BCAA
BCAA is a pharmaceutical drug with 13 clinical trials. Currently 3 active trials ongoing. Historical success rate of 87.5%.
Success Metrics
Based on 7 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
2
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
87.5%
7 of 8 finished
12.5%
1 ended early
3
trials recruiting
13
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
BCAAs in Concussion 3.0
BCAAs in Concussion 2.0
Impact of Preoperative Oral Branched-chain Amino Acids on Reducing Postoperative Insulin Resistance.
Acute Effects of BCAA and L-Arginine on Performance in Elite Soccer Players
Maintaining Immune and Mitochondrial Functions in Old Adults With SAfe Nutrition.
Clinical Trials (13)
BCAAs in Concussion 3.0
BCAAs in Concussion 2.0
Impact of Preoperative Oral Branched-chain Amino Acids on Reducing Postoperative Insulin Resistance.
Acute Effects of BCAA and L-Arginine on Performance in Elite Soccer Players
Maintaining Immune and Mitochondrial Functions in Old Adults With SAfe Nutrition.
Nutritional Assesment in Patients With Cirrhosis
Mechanisms to Reduce Mental and Physical Fatigue Following Exercise Training in Older Adults
Leucine-enriched Branched-chain Amino Acid on Muscle Thickness, Interleukin-6, SOFA Score in Critical Illness
BCAA in Patients Undergoing Gastric Cancer Surgery
Effect of Branched-chain Amino Acid Supplementation and Exercise on Muscle Quantity and Quality in Cirrhosis
Investigation of an Amino Acid Supplement on Glucose Levels in Obese Subjects
Comparison of Different Weight Loss Diets With Different Protein Content
Branched-chain Amino Acids Supplementation and Resistance Exercise-induced Muscle Damage and Inflammation
All 13 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 13